A panel of government health advisers said Friday there’s no clear evidence that a harder-to-crush version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or deaths.
The conclusion from the Food and Drug Administration advisory panel comes more than a decade after Purdue Pharma revamped its blockbuster opioid, which has long been blamed for sparking a surge in painkiller abuse beginning in the 1990s. Read More
Nine pharmaceutical companies signed a joint pledge Tuesday promising to prioritize safety and science regarding the development and distribution of a coronavirus vaccine.
The pledge is meant to counter declining public confidence in an eventual vaccine, Politico reported. An August CNN poll found that just over half of Americans would be willing to take a vaccine once developed, and a recent Politico poll found that over 60% of voters opposed the release of any vaccine that had not undergone full testing. Read More